Sarepta: Beat and Raise…Again?
October 26, 2017 at 11:27 AM EDT
Analysts are racing to lift price targets after this controversial drug maker delivered its third straight beat-and-raise quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.